We generated the line of transgenic animals (called rTgTauEC [reversible tau restricted to EC]) by crossing FVB-Tg(tetO-TauP301L)4510 mice (Santacruz et al., 2005) with a transgenic mouse line on a C57BL/6 genetic background OSI-744 expressing tet transactivator under the control of the neuropsin promoter (developed at The Scripps Research Institute [Yasuda and Mayford, 2006]). Only F1 offspring were used as experimental animals, ensuring a uniform 50:50 mix of FVB and C57BL/6 genetic

background. The human Tau gene with the P301L mutation in rTg4510 mice is downstream of a tetracycline-operon responsive element and requires the presence of the tet transactivator (Gossen and Bujard, 1992). Since the tet transactivator is downstream of the promoter of neuropsin, human tauP301L expression is restricted to EC-II. Mice with both the activator and responder transgenes are abbreviated rTgTauEC. Age-matched littermates expressing only the activator transgene and the responder transgene were used as controls. Mice were screened by PCR using the primer pairs 5′-ACCTGGACATGCTGTGATAA-3′and 5′-TGCTCCCATTCATCAGTTCC-3′ for activator transgenes and 5′-TGA ACC AGG ATG GCT GAG CC-3′ and 5′-TTG

TCA TCG CTT CCA GTC CCC G-3′ for responder transgenes. Each of the eight age groups MK1775 studied (3, 6, 9, 12, 15, 18, 21, 24 months) contained transgenic and control animals. A total of 183 animals were used for this study, including 97 transgenic and 86 control animals. All animal experiments were performed in accordance with national guidelines (National Institutes of Health) and approved by Massachusetts General Hospital and McLaughlin

Institute Institutional Animal Care first and Use Committees. Formalin-fixed, paraffin-embedded tissue specimens and frozen tissue from the temporal association isocortex (Brodmann area 38) of one patient with AD was obtained from the Massachusetts Alzheimer Disease Research Center Brain Bank. The study subject and their next of kin gave written informed consent for the brain donation, and the Massachusetts General Hospital Institutional Review Board approved the study protocol. The subject fulfilled the National Institute of Neurological and Communicative Disorders Alzheimer’s Disease and Related Disorders Association criteria for probable AD and the National Institute on Aging-Reagan criteria for high likelihood of AD. The animals were euthanized by CO2 asphyxiation and the brains harvested, fixed in 4% paraformaldehyde containing 15% glycerol cryoprotectant for 2 to 3 days, then either sectioned or stored at 4°C in a 20% sucrose solution.